basel agenda 2016 during the life science week 2016

+ConCep Think Tank & Strategy Consultant


2nd International Outcomes Symposium

The Basel Agenda 2016

Aspiration for Growth: A Roadmap

Basel, September 20th 2016


BA_2016_20160920_v1 2

Welcome to the Basel Agenda 2016

“Aspirational healthcare outcomes” Symposium

Two Panel discussions:

FocusGlobal disruption for Value Outcomes

Quality Health – Prevention to Post care

Business Models – Where/ How to win?

InteractionAudience Questions

Sli.do – Instant audience input to polls and

input on key questions for the future

“The Basel Agenda 2030 Report:

An aspirational Roadmap on Healthcare Transformation”

To be published in December 2016

Two Sessions:

Today’s Winners

What can we learn from innovative

healthcare value chains model

Beyond reimbursement

How disruptive strategies will impact

tomorrow’s healthcare delivery



Welcome our speakers

3BA_2016_20160920_v1


Manual Heuer

COO, dacadoo.com

Reto Schegg

CEO, Healthbank

Patrick Kersten

CEO, Doctena

Philipp Lichtenberg

Director Sales, Visionarity

Beatus Hofrichter (moderator)

Managing Director, ConCeplus

Aleksandar Ruzicic (moderator)

Partner, Executive Insight/ INSEAD Alumni Association Switzerland

The speakers

(in order of

appearance)


Three step approach for Session I

4BA_2016_20160920_v1


Step

Duration

1. Opening

presentation

2. Panel

discussion

3. Q&A with the

audience

<60 minutes 45+ minutes <30 minutes

Welcome and food

for thought

Speakers intro-

ductions

Opening statements

(up to 15 minutes)

How will digital/ ICT

IMPACT healthcare?

Which digital/ ICT

TRENDS will impact

healthcare most?

Where will digital/ ICT

healthcare LEADERS

come from?

Introduce yourself

with name/affiliation

Make your

contributions

Target a question to

panel member(s)


The experts combine a variety of perspectives

together

5BA_2016_20160920_v1


DR. JÜRGEN RATHS

Variety of perspectives…

…across many ICT disciplines and sectors (mainly private perspective)

…as managers/leaders and innovators/ visionars

…on quality health, ICT, and potentials customer behavior impact

Manuel Heuer

COO Dacadoo

Senior roles at

innovation leaders in

Medtech (St. Jude -

CH, Boston Scientific)

Reto Schegg

CEO Healthbank

Leading roles in ICT

companies (incl.

Swisscom) and Health

insurance

Patrick Kersten

CEO Doctena

20 years of ICT start-

up experience

Creative

entrepreneurs

Philipp Lichtenberg

Director Sales

Visionarity

Focus on consumer

marketing, healthcare

sustainability, speech

and facial recognition






TODAY‘S WINNERSWhat can we learn from innovative healthcare value chains model

A visionary forum for Healthcare & Life Science

stakeholders & corporate decision makers



BA_2016_20160920_v1 7

Basel Agenda 2016 – Session I

Today‘s Winners

Influencing personal health & wellbeing via

wearables & health promoting platforms

Manuel Heuer

COO

dacadoo



BA_2016_20160920_v1 8


Today‘s Winners

When consumer health and health care delivery

is aligned!

Reto Schegg

CEO

Healthbank.org



BA_2016_20160920_v1 9


Today‘s Winners

How booking platforms will influence patient

journeys

Patrick Kerster

CEO

Doctena



BA_2016_20160920_v1 10


Today‘s Winners

New adherence potentials in joint B2C models

Phil Lichtenberg

Director Sales

Visionarity



11


Today‘s Winners

Today’s Winners - A very brief outlook

Beatus Hofrichter

Managing Director

Conceplus



BA_2016_20160920_v1 12

A „Quality Health“ driven offering focus will drive

future growth

Source: B. Hofrichter, A. Ruzicic, Dr. P. Dümmler “GMTI 2013 Report – Accelerating Transformation for Success”



BA_2016_20160920_v1 13

Tomorrows demand calls for new offering

structure

Connectivity

Source : ConCep+; McKinsey & Co, April 2015

Mobil Devices

Integration

Internet of Things

Integration

Traditional MedTech

Offering

Product Services Data Apps

Remark: This model illustrates the dynamics and changes facing Medtech offering structures as a result emerging IoT technologies. It is a model developed

by CC+ market insights, based on secondary research and expert discussions. This graph solely provides an indicative high-level viewpoint. We recommend a thorough product strategy review within and across all portfolio offerings to analyze any potential future strategic gaps.

0% 25% 50% 75% 100%

Todays Offering

Future Offering

© 2016. ConCep+

Mobil Devices

Integration

IoT Integration

Traditional Offering



Holistic lock-up strategies are unfolding (and in Pharma/Biotech)

Within firms span of control External parties

14

… appliying global ICT process data “game”

Telehealth Home nurse Pharmacies GP

Private specialists/ Secondary

care

ICT

Pharma/ Biotech

Medtech

Regulations

Clinical Data Mgmt.

Local event predictionon

Cold, Flu, and Allergies

Bio-electronics

BA_2016_20160920_v1



Holistic lock-up strategies are unfolding, …..(in Medtech)

Within firms span of control External parties

15

Mobil OPs KOL teams Home/ Post Care

Coordinate

DRG

holistically

MedTech Manufacturer

GP

Top KOL team

Logistics

OP Planning

Post OP Care

DRG adaptation

Gov. Adm.

QA/Monitoring

Suppliers

Fully integrated

Disease Management

Strategy

Fully integrated

Disease Management

Offerings

Fully integrated

Disease Management

Processes & IT landscape

Sys Library

Performance /

Outcome/ QA

Solutions

Vendor Mgmt &

Inventory

Solutions

Vendor A

Vendor B

Vendor D

Vendor X

Vendor E

Vendor C

QA

evaluation

… applying global holistic process interface “game”

BA_2016_20160920_v1



BA_2016_20160920_v1 16


Today‘s Winners

Today’s Winners – Panel discussion



BSLW WLAN

17BA_2016_20160920_v1



You can participate today in two different ways

18BA_2016_20160920_v1


1. Open a browser on your smart device

2. Go to the website www.slido.com

3. Type-in the event code #3322

Post new questions/

endorse posted ones

(to ask the panel)

Answer a poll and

see the real-time

results on the screen


Now, it is your turn to get involved and ask

questions!

19BA_2016_20160920_v1


Please

Introduce yourself with name/affiliation

Make your contributions

Target a question to panel member(s)

Manuel Heuer Reto Schegg Patrick Kersten Philipp Lichtenberg






BEYOND REIMBURSEMENTHow disruptive strategy impacts healthcare delivery tomorrow

A visionary forum for Healthcare & Life Science

stakeholders & corporate decision makers

Basel September 20, 2016

Convergence of digital & genomic revolutions

with health, healthcare, living, and society

From 2009… … until 20XY?


Welcome our speakers

21BA_2016_20160920_v1


Herb Riband

Vice President Value, Access & Policy, Amgen (Europe)

Zayna Khayat

Senior Advisor, Health System Innovation and Director, MaRS EXCIT

Ben van Ommen

TNO – The Netherlands Organisation for Applied Scientific Research

Aleksandar Ruzicic (moderator)

Partner, Executive Insight/ INSEAD Alumni Association Switzerland

Beatus Hofrichter (moderator)

Managing Director, ConCeplus

The speakers

(in order of

appearance)


Three step approach for Session II

22BA_2016_20160920_v1


Step

Duration

1. Opening

presentation

2. Panel

discussion

3. Q&A with the

audience

<60 minutes 45+ minutes <30 minutes

Welcome and food for

thought

Speakers intro-

ductions

Opening statements

(up to 15 minutes)

What is VALUE in

healthcare?

Which factors drive

healthcare

DISRUPTION?

Who are the future

healthcare

LEADERS?

Introduce yourself

with name/affiliation

Make your

contributions

Target a question to

panel member(s)


The experts combine a variety of perspectives

together

23BA_2016_20160920_v1


DR. JÜRGEN RATHS

Variety of perspectives…

…across many healthcare sectors, including public/ private perspectives

…as managers/leaders and innovators/ researchers

…on medicine, science and healthcare systems/ Eucomed

Herb Riband

Biotech (Amgen) and medtech

(Medtronic) senior executive

Leading roles in associations,

(EBE/EFPIA, Eucomed, etc.)

Zayna Khayat

Health system innovation from

start-up/ Ontario perspective

Strategy consulting in global

health and life sciences sector

Ben van Ommen

Applied systems biology

to metabolic health

Integrated solutions for

personal health


BA_2016_20160920_v1 24

Basel Agenda 2016 – Session II

Beyond Reimbursement

Bringing greater value to EU healthcare systems:

Maximizing outcomes & optimizing costs

Herb Riband

Vice President Value, Access & Policy

Amgen (Europe)



25



Canada: a destiny for healthcare innovators

Zayna Khayat

Senior Advisor, Health System Innovation and Director

MaRS EXCIT



26



How can we make type 2 diabetes 13 times cheaper and cure the patients in doing so?

Ben van Ommen

Principle Investigor

TNO - The Netherlands Organisation for applied scientific

research



27



Beyond Reimbursement – Food for thought

Aleksandar Ruzicic

Partner

Executive Insight



What is VALUE in healthcare?

28BA_2016_20160920_v1


Value-based competition in healthcare principles

1. Increase value for patients

2. Demonstrate real-world results

3. Focus on medical conditions over full cycle of care

4. Build experience, scale & learning for a medical condition

5. Compete beyond local geographies, ideally globally

6. Create data & transparency on all value aspects

Source: Porter/ Teisberg “Value-based competition in healthcare”, “Redefining Health Care”

Outcome

Total costs

How can one show

improvement over

Standard-of-Care?

Why is there not

more competition on

(lower) costs?


Where can we find VALUE benchmarks?

29BA_2016_20160920_v1


Breast cancer OUTCOMES

5-year survival rates (stages 1-3 combined)

Healthcare Global (India) 86.9% (97% of US)

US average 89.2%

Cancer treatment COSTS

Full set of intensity modulated radiation

treatments

Healthcare Global (India) US$ 2,900 (13% of US)

US average US$ 22,000

* High-precision, robotic radiosurgery system (costing US$ 8 million)

Source: HCG, “Delivering World-Class Healthcare Affordably”/ HBR

Super-hub: 1

Bangalore (is also serving

as a hub in the network)

Center of Excellence for

the overall chain

Most highly trained

oncologists & pathologists

Unique equipment, e.g.

Cyberknife*

Regional hubs: 3+1

Ahmedabad, Mumbai,

Chennai (and Bangalore)

Sophisticated procedures and

surgery (patient channeling)

Oncology specialists (also

leveraging telemedicine)

High-end equipment, e.g.

PET-CT scanners, cyclotrons

Spokes: 17

Gateways around the four

hubs (first patient contact)

Diagnosis, routine treatment

and follow-up care

Oncologists (access to

databases/ algorithms/ tools)

Standard equipment and two-

way audio/video capability


Which factors drive healthcare DISRUPTION?

30BA_2016_20160920_v1


Managing Healthcare

Financing Healthcare

Competing in Healthcare

Managing consistently against costs and quality criteria

Specialization within healthcare delivery, e.g. dialysis chains

Superior brand appealing to the “informed” patient

Outcome based payments, also considering quality

Voluntary “out-of-pocket” consumer spending

Privatizations given growing public deficits

Globalization of healthcare, e.g. patients, professionals, providers

Healthcare product companies forward integrating into healthcare

Novel virtual value chains exploiting knowledge and data better

Source: 2nd Global Medtech Industry Report 2014


Which companies are shaping the disruption?

31BA_2016_20160920_v1


Fully integrated Disease Management

Strategy

Fully integrated Disease Management

Offerings

Fully integrated

Disease Management

Processes & IT landscape

EUropean Clinical DB for Dialysis (KPIs!)

§ Original database

created in 1998

§ Benchmarking in

Germany since 2002

§ Covering all EU

dialysis since 2014

(100,000+ patients)

Source: Fresenius home page and reports

EuCliD

Database

1998

Care

Coordination

2013

Predictive

Analytics

2015

Care Coordination (with revenue target)

§ Bundled non-dialysis

services since 2013

§ Based on internal

COM-Ex & OP-EX

§ From individual

services to holistic and

coordinated care

Renal Research Institute (scientific arm)

§ “Big Data” modeling for renal care

since 2015

§ Outcomes monitoring and

predictions for high risk patients

§ Lower costs from major reductions

in hospital admissions and stays


Who are the future LEADERS in healthcare?

32BA_2016_20160920_v1


Integrated healthcare products/ services

International providers

Telemedicine players

ICT/ data players

Healthcare product companies

Specialized healthcare players

Selected examples Type of players


Where will the future healthcare leaders come

from?

33BA_2016_20160920_v1



BA_2016_20160920_v1 34



Beyond reimbursement – Panel discussion



BSLW WLAN

35BA_2016_20160920_v1



You can participate today in two different ways

36BA_2016_20160920_v1


1. Open a browser on your smart device

2. Go to the website www.slido.com

3. Type-in the event code #3322

Post new questions/

endorse posted ones

(to ask the panel)

Answer a poll and

see the real-time

results on the screen


Now, it is your turn to get involved and ask

questions!

37BA_2016_20160920_v1


Please

Introduce yourself with name/affiliation

Make your contributions

Target a question to panel member(s)

Herb Riband Zayna Khayat Ben van Ommen


Your hosts stand for ….

38BA_2016_20160920_v1



Visionary thinking on

holistic Business Model

Innovation for Healthcare &

Life Science Stakeholders



ConCeplus GmbH ist eine im Luzerner Handelsregister

eingetragene Unternehmensberatung.

Handelsregister Nr: CHE-459.633.547

Diese Publikation kann sich zum Teil auf Daten Dritte stützen,

die dann nach besten Wissen und Gewissen verwendet

wurden. Für allfällige Irrtümer ab Datenquelle übernimmt

ConCep+ keine Haftung.

Alle Inhalte, Ideen, Konzepte und Bilder sind urheberrechtlich

geschützt. Das Erstellen von Kopien im Ganzen oder in Teilen

ist untersagt; Ausnahme bilden lediglich mandatsbezogene

Dokumentationen.

Anschrift:

ConCeplus GmbH

Lützelaustrasse 44

CH-6353 Weggis

+41 79 254 0968

[email protected]

www.conceplus.com

© ConCep+ 2015
